Interstitial lung disease (ILD) complicating connective tissue disorders, such as scleroderma
and rheumatoid arthritis, is associated with significant morbidity and mortality. Progress has …

Interstitial lung disease (ILD) is a frequent pulmonary manifestation and an important cause
of morbidity and mortality in patients with idiopathic inflammatory myopathy. Myositis-related …

Interstitial lung disease (ILD) is a common manifestation in connective tissue diseases
(CTD), such as rheumatoid arthritis (RA), systemic sclerosis (SSc), and inflammatory …

Objective Interstitial lung disease (ILD) is the most severe complication of idiopathic
inflammatory myositis (IIM), resulting in significant increase in morbidity and mortality and for …

Progressive fibrosing interstitial lung disease (PF-ILD) has been redefined as a new clinical
syndrome that shares similar genetics, pathophysiology, and natural history to idiopathic …

The lung is frequently involved in connective tissue diseases (CTDs), although the
frequency of lung manifestations varies according to the type of CTD. Interstitial lung …

ABSTRACT Background: Interstitial lung diseases (ILDs) are among the most serious
complications associated with systemic rheumatic diseases, and lead to significant morbidity …

Idiopathic pulmonary fibrosis (IPF) is a progressive pulmonary disease leading to death
within a few years of diagnosis despite medical therapy. On the basis of methodologies of …

Abstract Background Idiopathic Pulmonary Fibrosis (IPF) or Usual Interstitial Pneumonia
(UIP) is a form of chronic fibrosing interstitial pneumonia of unknown aetiology, with …

Background Interstitial lung disease (ILD) frequently complicates systemic autoimmune
disorders resulting in considerable morbidity and mortality. The connective tissue diseases …